img

Global HER2 Targeted Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global HER2 Targeted Therapy Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal HER2 Targeted Therapy Market
Global HER2 Targeted Therapy market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, HER2 Targeted Therapy industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, HER2 Targeted Therapy key companies include GlaxoSmithKline, Bayer, Abbott, AbbVie, Pfizer, Sanofi, Agilent, Glenmark Pharmaceuticals and Merck, etc. GlaxoSmithKline, Bayer, Abbott are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of HER2 Targeted Therapy were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole HER2 Targeted Therapy market and estimated to attract more attentions from industry insiders and investors.
HER2 Targeted Therapy can be divided into Monotherapy, Combination Therapy and Others,, etc. Monotherapy is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
HER2 Targeted Therapy is widely used in various fields, such as Breast Cancer, Stomach Cancer, Head and Neck Cancer and Lung Cancer, etc. Breast Cancer provides greatest supports to the HER2 Targeted Therapy industry development. In 2022, global % revenue of HER2 Targeted Therapy went into Breast Cancer filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global HER2 Targeted Therapy market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global HER2 Targeted Therapy market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Bayer
Abbott
AbbVie
Pfizer
Sanofi
Agilent
Glenmark Pharmaceuticals
Merck
Roche
Novartis
Astra Zeneca
Daiichi Sankyo
Segment by Type
Monotherapy
Combination Therapy
Others

Segment by Application


Breast Cancer
Stomach Cancer
Head and Neck Cancer
Lung Cancer
Ovarian Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, HER2 Targeted Therapy introduction, etc. HER2 Targeted Therapy Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of HER2 Targeted Therapy
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 Targeted Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global HER2 Targeted Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Breast Cancer
1.3.3 Stomach Cancer
1.3.4 Head and Neck Cancer
1.3.5 Lung Cancer
1.3.6 Ovarian Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HER2 Targeted Therapy Market Perspective (2018-2033)
2.2 Global HER2 Targeted Therapy Growth Trends by Region
2.2.1 HER2 Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 HER2 Targeted Therapy Historic Market Size by Region (2018-2023)
2.2.3 HER2 Targeted Therapy Forecasted Market Size by Region (2024-2033)
2.3 HER2 Targeted Therapy Market Dynamics
2.3.1 HER2 Targeted Therapy Industry Trends
2.3.2 HER2 Targeted Therapy Market Drivers
2.3.3 HER2 Targeted Therapy Market Challenges
2.3.4 HER2 Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue HER2 Targeted Therapy by Players
3.1.1 Global HER2 Targeted Therapy Revenue by Players (2018-2023)
3.1.2 Global HER2 Targeted Therapy Revenue Market Share by Players (2018-2023)
3.2 Global HER2 Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of HER2 Targeted Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global HER2 Targeted Therapy Market Concentration Ratio
3.4.1 Global HER2 Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 Targeted Therapy Revenue in 2022
3.5 Global Key Players of HER2 Targeted Therapy Head office and Area Served
3.6 Global Key Players of HER2 Targeted Therapy, Product and Application
3.7 Global Key Players of HER2 Targeted Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 Targeted Therapy Breakdown Data by Type
4.1 Global HER2 Targeted Therapy Historic Market Size by Type (2018-2023)
4.2 Global HER2 Targeted Therapy Forecasted Market Size by Type (2024-2033)
5 HER2 Targeted Therapy Breakdown Data by Application
5.1 Global HER2 Targeted Therapy Historic Market Size by Application (2018-2023)
5.2 Global HER2 Targeted Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America HER2 Targeted Therapy Market Size (2018-2033)
6.2 North America HER2 Targeted Therapy Market Size by Type
6.2.1 North America HER2 Targeted Therapy Market Size by Type (2018-2023)
6.2.2 North America HER2 Targeted Therapy Market Size by Type (2024-2033)
6.2.3 North America HER2 Targeted Therapy Market Share by Type (2018-2033)
6.3 North America HER2 Targeted Therapy Market Size by Application
6.3.1 North America HER2 Targeted Therapy Market Size by Application (2018-2023)
6.3.2 North America HER2 Targeted Therapy Market Size by Application (2024-2033)
6.3.3 North America HER2 Targeted Therapy Market Share by Application (2018-2033)
6.4 North America HER2 Targeted Therapy Market Size by Country
6.4.1 North America HER2 Targeted Therapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America HER2 Targeted Therapy Market Size by Country (2018-2023)
6.4.3 North America HER2 Targeted Therapy Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe HER2 Targeted Therapy Market Size (2018-2033)
7.2 Europe HER2 Targeted Therapy Market Size by Type
7.2.1 Europe HER2 Targeted Therapy Market Size by Type (2018-2023)
7.2.2 Europe HER2 Targeted Therapy Market Size by Type (2024-2033)
7.2.3 Europe HER2 Targeted Therapy Market Share by Type (2018-2033)
7.3 Europe HER2 Targeted Therapy Market Size by Application
7.3.1 Europe HER2 Targeted Therapy Market Size by Application (2018-2023)
7.3.2 Europe HER2 Targeted Therapy Market Size by Application (2024-2033)
7.3.3 Europe HER2 Targeted Therapy Market Share by Application (2018-2033)
7.4 Europe HER2 Targeted Therapy Market Size by Country
7.4.1 Europe HER2 Targeted Therapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe HER2 Targeted Therapy Market Size by Country (2018-2023)
7.4.3 Europe HER2 Targeted Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China HER2 Targeted Therapy Market Size (2018-2033)
8.2 China HER2 Targeted Therapy Market Size by Type
8.2.1 China HER2 Targeted Therapy Market Size by Type (2018-2023)
8.2.2 China HER2 Targeted Therapy Market Size by Type (2024-2033)
8.2.3 China HER2 Targeted Therapy Market Share by Type (2018-2033)
8.3 China HER2 Targeted Therapy Market Size by Application
8.3.1 China HER2 Targeted Therapy Market Size by Application (2018-2023)
8.3.2 China HER2 Targeted Therapy Market Size by Application (2024-2033)
8.3.3 China HER2 Targeted Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia HER2 Targeted Therapy Market Size (2018-2033)
9.2 Asia HER2 Targeted Therapy Market Size by Type
9.2.1 Asia HER2 Targeted Therapy Market Size by Type (2018-2023)
9.2.2 Asia HER2 Targeted Therapy Market Size by Type (2024-2033)
9.2.3 Asia HER2 Targeted Therapy Market Share by Type (2018-2033)
9.3 Asia HER2 Targeted Therapy Market Size by Application
9.3.1 Asia HER2 Targeted Therapy Market Size by Application (2018-2023)
9.3.2 Asia HER2 Targeted Therapy Market Size by Application (2024-2033)
9.3.3 Asia HER2 Targeted Therapy Market Share by Application (2018-2033)
9.4 Asia HER2 Targeted Therapy Market Size by Region
9.4.1 Asia HER2 Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia HER2 Targeted Therapy Market Size by Region (2018-2023)
9.4.3 Asia HER2 Targeted Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline HER2 Targeted Therapy Introduction
11.1.4 GlaxoSmithKline Revenue in HER2 Targeted Therapy Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer HER2 Targeted Therapy Introduction
11.2.4 Bayer Revenue in HER2 Targeted Therapy Business (2018-2023)
11.2.5 Bayer Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott HER2 Targeted Therapy Introduction
11.3.4 Abbott Revenue in HER2 Targeted Therapy Business (2018-2023)
11.3.5 Abbott Recent Developments
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie HER2 Targeted Therapy Introduction
11.4.4 AbbVie Revenue in HER2 Targeted Therapy Business (2018-2023)
11.4.5 AbbVie Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer HER2 Targeted Therapy Introduction
11.5.4 Pfizer Revenue in HER2 Targeted Therapy Business (2018-2023)
11.5.5 Pfizer Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi HER2 Targeted Therapy Introduction
11.6.4 Sanofi Revenue in HER2 Targeted Therapy Business (2018-2023)
11.6.5 Sanofi Recent Developments
11.7 Agilent
11.7.1 Agilent Company Details
11.7.2 Agilent Business Overview
11.7.3 Agilent HER2 Targeted Therapy Introduction
11.7.4 Agilent Revenue in HER2 Targeted Therapy Business (2018-2023)
11.7.5 Agilent Recent Developments
11.8 Glenmark Pharmaceuticals
11.8.1 Glenmark Pharmaceuticals Company Details
11.8.2 Glenmark Pharmaceuticals Business Overview
11.8.3 Glenmark Pharmaceuticals HER2 Targeted Therapy Introduction
11.8.4 Glenmark Pharmaceuticals Revenue in HER2 Targeted Therapy Business (2018-2023)
11.8.5 Glenmark Pharmaceuticals Recent Developments
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck HER2 Targeted Therapy Introduction
11.9.4 Merck Revenue in HER2 Targeted Therapy Business (2018-2023)
11.9.5 Merck Recent Developments
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche HER2 Targeted Therapy Introduction
11.10.4 Roche Revenue in HER2 Targeted Therapy Business (2018-2023)
11.10.5 Roche Recent Developments
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis HER2 Targeted Therapy Introduction
11.11.4 Novartis Revenue in HER2 Targeted Therapy Business (2018-2023)
11.11.5 Novartis Recent Developments
11.12 Astra Zeneca
11.12.1 Astra Zeneca Company Details
11.12.2 Astra Zeneca Business Overview
11.12.3 Astra Zeneca HER2 Targeted Therapy Introduction
11.12.4 Astra Zeneca Revenue in HER2 Targeted Therapy Business (2018-2023)
11.12.5 Astra Zeneca Recent Developments
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Details
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo HER2 Targeted Therapy Introduction
11.13.4 Daiichi Sankyo Revenue in HER2 Targeted Therapy Business (2018-2023)
11.13.5 Daiichi Sankyo Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global HER2 Targeted Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Key Players of Others
Table 5. Global HER2 Targeted Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global HER2 Targeted Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global HER2 Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global HER2 Targeted Therapy Market Share by Region (2018-2023)
Table 9. Global HER2 Targeted Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global HER2 Targeted Therapy Market Share by Region (2024-2033)
Table 11. HER2 Targeted Therapy Market Trends
Table 12. HER2 Targeted Therapy Market Drivers
Table 13. HER2 Targeted Therapy Market Challenges
Table 14. HER2 Targeted Therapy Market Restraints
Table 15. Global HER2 Targeted Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global HER2 Targeted Therapy Revenue Share by Players (2018-2023)
Table 17. Global Top HER2 Targeted Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Targeted Therapy as of 2022)
Table 18. Global HER2 Targeted Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by HER2 Targeted Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of HER2 Targeted Therapy, Headquarters and Area Served
Table 21. Global Key Players of HER2 Targeted Therapy, Product and Application
Table 22. Global Key Players of HER2 Targeted Therapy, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global HER2 Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global HER2 Targeted Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global HER2 Targeted Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global HER2 Targeted Therapy Revenue Market Share by Type (2024-2033)
Table 28. Global HER2 Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global HER2 Targeted Therapy Revenue Share by Application (2018-2023)
Table 30. Global HER2 Targeted Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global HER2 Targeted Therapy Revenue Share by Application (2024-2033)
Table 32. North America HER2 Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America HER2 Targeted Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America HER2 Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America HER2 Targeted Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America HER2 Targeted Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America HER2 Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America HER2 Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe HER2 Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe HER2 Targeted Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe HER2 Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe HER2 Targeted Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe HER2 Targeted Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe HER2 Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe HER2 Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. China HER2 Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 47. China HER2 Targeted Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 48. China HER2 Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 49. China HER2 Targeted Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia HER2 Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia HER2 Targeted Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia HER2 Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia HER2 Targeted Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia HER2 Targeted Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia HER2 Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia HER2 Targeted Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America HER2 Targeted Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline HER2 Targeted Therapy Product
Table 67. GlaxoSmithKline Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 68. GlaxoSmithKline Recent Developments
Table 69. Bayer Company Details
Table 70. Bayer Business Overview
Table 71. Bayer HER2 Targeted Therapy Product
Table 72. Bayer Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 73. Bayer Recent Developments
Table 74. Abbott Company Details
Table 75. Abbott Business Overview
Table 76. Abbott HER2 Targeted Therapy Product
Table 77. Abbott Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 78. Abbott Recent Developments
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie HER2 Targeted Therapy Product
Table 82. AbbVie Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 83. AbbVie Recent Developments
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer HER2 Targeted Therapy Product
Table 87. Pfizer Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 88. Pfizer Recent Developments
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi HER2 Targeted Therapy Product
Table 92. Sanofi Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 93. Sanofi Recent Developments
Table 94. Agilent Company Details
Table 95. Agilent Business Overview
Table 96. Agilent HER2 Targeted Therapy Product
Table 97. Agilent Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 98. Agilent Recent Developments
Table 99. Glenmark Pharmaceuticals Company Details
Table 100. Glenmark Pharmaceuticals Business Overview
Table 101. Glenmark Pharmaceuticals HER2 Targeted Therapy Product
Table 102. Glenmark Pharmaceuticals Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 103. Glenmark Pharmaceuticals Recent Developments
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck HER2 Targeted Therapy Product
Table 107. Merck Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 108. Merck Recent Developments
Table 109. Roche Company Details
Table 110. Roche Business Overview
Table 111. Roche HER2 Targeted Therapy Product
Table 112. Roche Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 113. Roche Recent Developments
Table 114. Novartis Company Details
Table 115. Novartis Business Overview
Table 116. Novartis HER2 Targeted Therapy Product
Table 117. Novartis Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 118. Novartis Recent Developments
Table 119. Astra Zeneca Company Details
Table 120. Astra Zeneca Business Overview
Table 121. Astra Zeneca HER2 Targeted Therapy Product
Table 122. Astra Zeneca Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 123. Astra Zeneca Recent Developments
Table 124. Daiichi Sankyo Company Details
Table 125. Daiichi Sankyo Business Overview
Table 126. Daiichi Sankyo HER2 Targeted Therapy Product
Table 127. Daiichi Sankyo Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 128. Daiichi Sankyo Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HER2 Targeted Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global HER2 Targeted Therapy Market Share by Type: 2022 VS 2033
Figure 3. Monotherapy Features
Figure 4. Combination Therapy Features
Figure 5. Others Features
Figure 6. Global HER2 Targeted Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global HER2 Targeted Therapy Market Share by Application: 2022 VS 2033
Figure 8. Breast Cancer Case Studies
Figure 9. Stomach Cancer Case Studies
Figure 10. Head and Neck Cancer Case Studies
Figure 11. Lung Cancer Case Studies
Figure 12. Ovarian Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. HER2 Targeted Therapy Report Years Considered
Figure 15. Global HER2 Targeted Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global HER2 Targeted Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global HER2 Targeted Therapy Market Share by Region: 2022 VS 2033
Figure 18. Global HER2 Targeted Therapy Market Share by Players in 2022
Figure 19. Global Top HER2 Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Targeted Therapy as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by HER2 Targeted Therapy Revenue in 2022
Figure 21. North America HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America HER2 Targeted Therapy Market Share by Type (2018-2033)
Figure 23. North America HER2 Targeted Therapy Market Share by Application (2018-2033)
Figure 24. North America HER2 Targeted Therapy Market Share by Country (2018-2033)
Figure 25. United States HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe HER2 Targeted Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe HER2 Targeted Therapy Market Share by Type (2018-2033)
Figure 29. Europe HER2 Targeted Therapy Market Share by Application (2018-2033)
Figure 30. Europe HER2 Targeted Therapy Market Share by Country (2018-2033)
Figure 31. Germany HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China HER2 Targeted Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China HER2 Targeted Therapy Market Share by Type (2018-2033)
Figure 39. China HER2 Targeted Therapy Market Share by Application (2018-2033)
Figure 40. Asia HER2 Targeted Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia HER2 Targeted Therapy Market Share by Type (2018-2033)
Figure 42. Asia HER2 Targeted Therapy Market Share by Application (2018-2033)
Figure 43. Asia HER2 Targeted Therapy Market Share by Region (2018-2033)
Figure 44. Japan HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America HER2 Targeted Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America HER2 Targeted Therapy Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America HER2 Targeted Therapy Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America HER2 Targeted Therapy Market Share by Country (2018-2033)
Figure 54. Brazil HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. GlaxoSmithKline Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 61. Bayer Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 62. Abbott Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 63. AbbVie Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 64. Pfizer Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 65. Sanofi Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 66. Agilent Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 67. Glenmark Pharmaceuticals Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 68. Merck Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 69. Roche Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 70. Novartis Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 71. Astra Zeneca Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 72. Daiichi Sankyo Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries